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To the Editors
Parapneumonic empyema (PPE) is a serious complication of bacterial pneumonia in children 
that is increasingly reported in the U.S. 1. Identification of pathogens causing PPE has 
generally relied on culture, however in up to 70%of cases pleural fluid cultures are 
negative2–4. The high rate of culture-negative disease complicates clinical care and selection 
of appropriate antibiotics.
Culture-independent techniques such as 16S polymerase chain reaction (PCR) have been 
used to determine the etiology of PPE2–5. However, some studies have shown limitations to 
its sensitivity 3, 5. Our previously published studies demonstrated the efficacy of genus and 
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species-specific assays to detect pathogens causing PPE4. Here we directly compared the 
sensitivity of pathogen detection using genus and species-specific PCR to that obtained 
withbroad-range16SPCR.
This study was approved by the Children’s Hospital of Philadelphia (CHOP) Committees 
for the Protection of Human Subjects and was exempt from IRB oversight at the University 
of Utah. Samples were collected at CHOP to assess the diagnostic accuracy of broad-range 
16S PCR5. Patient selection, sample collection methods and 16S PCR methodology have 
been previously described 5. Residual frozen pleural fluid samples were transferred to the 
University of Utah and Idaho Technology, Inc. (now BioFire Diagnostics, Inc.)for analysis 
by genus and species-specific PCR as previously described 4. Results of conventional 
culture were compared to results of 16S and species-specific PCR using McNemar’s test.
Twenty-five pleural fluid samples underwent testing with both 16S and genus/species-
specific PCR. Culture of pleural fluid and/or blood identified a pathogen in 6 (24%)children 
and16S PCR of pleural fluid identified a pathogen in 3 (12%). Genus or species-specific 
PCR identified at least one bacterial pathogen in pleural fluid samples from 22of 25children 
(88%; p < 0.001 for comparison to both culture and 16S PCR). Species-specific assays most 
commonly detected and identified S. pneumoniae (56% of cases). MRSA was detected in 
one pleural fluid specimen (4%) that was also culture positive. In two cases polymicrobial 
infection was detected by species-specific PCR. Detailed results are shown in the Table, 
Supplemental Digital Content 1, http://links.lww.com/INF/B385. This table shows the 
detailed comparison, by organism, of species-specific PCR vs. 16S PCR and conventional 
culture of pleural fluid and blood.
This study directly compares pathogen detection using 16S PCR to PCR specifically 
targeting pneumonia-causing bacteria in pleural fluid from children with complicated 
pneumonia. 16S PCR did not improve detection of bacteria, however species-specific PCR 
significantly increased pathogen detection with a positivity rate of 88%. S. pneumoniae was 
the most common pathogen identified. MRSA was detected only once, in a culture-positive 
specimen.
The significantly improved yield of species-specific PCR indicates that PCR methodology is 
an important consideration for molecular detection of pathogens in pneumonia. While 
outside the scope of this study, further analysis of results at the patient-level could inform 
testing algorithms regarding the utility of broad range vs. specific PCR in certain 
populations. As testing costs decrease and multiplex testing is more often available, the 
feasibility and cost of performing multiple specific PCR tests on a single sample will 
improve.
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